SELECT * FROM `stock_list` where symbol='CENTRALPHL' AND exchange = 'DHA' limit 0,1
SELECT * FROM `stock_list` where symbol='CENTRALPHL' AND exchange = 'DHA' limit 0,1
SELECT * FROM `stock_list` WHERE `symbol` = "CENTRALPHL" and stock_list.exchange IN (SELECT exchange FROM gurufocu_main.stock_list_exchanges where country='USA' and active=1) limit 0,1 Central Pharmaceuticals (DHA:CENTRALPHL) Accounts Receivabl
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Central Pharmaceuticals Ltd (DHA:CENTRALPHL) » Definitions » Accounts Receivable

Central Pharmaceuticals (DHA:CENTRALPHL) Accounts Receivable : BDT78.92 Mil (As of Sep. 2022)


View and export this data going back to 2013. Start your Free Trial

What is Central Pharmaceuticals Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Central Pharmaceuticals's accounts receivables for the quarter that ended in Sep. 2022 was BDT78.92 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Central Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Sep. 2022 was 1,152.84.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Central Pharmaceuticals's Net-Net Working Capital per share for the quarter that ended in Sep. 2022 was BDT-4.34.


Central Pharmaceuticals Accounts Receivable Historical Data

The historical data trend for Central Pharmaceuticals's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Central Pharmaceuticals Accounts Receivable Chart

Central Pharmaceuticals Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Accounts Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 597.92 56.02 79.05 79.10 80.40

Central Pharmaceuticals Quarterly Data
Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Jun19 Sep19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Jun23
Accounts Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 79.08 79.27 79.10 78.92 80.40

Central Pharmaceuticals Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.


Central Pharmaceuticals Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Central Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Sep. 2022 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=78.924/6.247*91
=1,152.84

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Central Pharmaceuticals's accounts receivable are only considered to be worth 75% of book value:

Central Pharmaceuticals's Net-Net Working Capital Per Share for the quarter that ended in Sep. 2022 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(1.533+0.75 * 78.924+0.5 * 34.784-597.516
-0-0)/119.801
=-4.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


Central Pharmaceuticals Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Central Pharmaceuticals's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Central Pharmaceuticals (DHA:CENTRALPHL) Business Description

Traded in Other Exchanges
N/A
Address
South West Darus Salam Road, 2-A/1, 2nd Floor, Mirpur - 1, Dhaka, BGD, 1216
Central Pharmaceuticals Ltd is engaged in the manufacturing and marketing of medicines in Bangladesh. The company manufactures finished formulation products for general people, hospitals, clinics, government organizations, corporations, and other non-government organizations. Its product portfolio encompasses therapeutic categories including gastrointestinal, anti-infective, vitamins and minerals, allergy cough and cold, analgesic and musculoskeletal, dermatological, oral rehydration salt, and others. The products are in the dosage forms of tablets, capsules, liquid, and ointments.

Central Pharmaceuticals (DHA:CENTRALPHL) Headlines

No Headlines